Here are relevant reports on : automated-insulin-delivery-systems-market
-
Wearable Healthcare Devices Market by Product (Trackers, Smartwatch, Patches), Type (Diagnostic (Vital Sign, ECG, Glucose), Therapeutic (Pain, Insulin)), Grade (Consumer, Clinical), Channel (Online, Pharmacy), Application (RPM) - Global Forecast to 2030
The global wearable healthcare devices market, valued at US$41.07 billion in 2024, stood at US$45.29 billion in 2025 and is projected to advance at a resilient CAGR of 10.9% from 2025 to 2030, culminating in a forecasted valuation of US$75.98 billion by the end of the period. Market growth is driven by rising health awareness, a shift toward preventive care, and the increasing prevalence of chronic conditions in aging populations.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
US Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User (Self/Home Healthcare) - Forecast to 2031
The US digital diabetes management market, valued at US$11.19 billion in 2025, stood at US$12.94 billion in 2026 and is projected to advance at a resilient CAGR of 11.9% from 2026 to 2031, culminating in a forecasted valuation of US$22.67 billion by the end of the period. The growth of the US digital diabetes management market is driven by the integration of AI-driven analytics, telehealth platforms, and interoperable ecosystems, which enhance clinical outcomes and patient engagement.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Infusion Pump Software Market by Type (DERS, Interoperability, Clinical Workflow), Indication (General Infusion, Pain & Anesthesia Management, Insulin Infusion), End User (Hospitals, Ambulatory Care Settings) - Global Forecasts to 2024
The market for infusion pump software is expected to grow USD 1,044 million by 2024, at a CAGR of 7.1% during the forecast period. The major vendors in the global infusion pump software market are BD (US), B. Braun (Germany), Baxter (US), ICU Medical (US), Terumo Medical (Japan), Fresenius Kabi (Germany), Moog (US), F. Hoffmann-La Roche (Switzerland), Ypsomed (Switzerland), Medtronic (Ireland), Smiths Medical (US), and Micrel Medical Devices (Greece).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Infusion Pump Market by Product (Accessories (Dedicated, Non-dedicated), Devices (Insulin, Syringe, Volumetric, Enteral, PCA Pump)), Technology (Traditional, Specialty), Mode (Stationary, Portable), Application (Cancer, Diabetes) - Global Forecast to 2030
The global infusion pump market, valued at US$18.5 billion in 2024, stood at US$19.9 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2025 to 2030, culminating in a forecasted valuation of US$ 28.3 billion by the end of the period. The infusion pump market is expanding rapidly, driven by significant technological advancements in smart, interconnected, and automated systems that optimize the precision and safety of infusion therapy.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
ASEAN Infusion Pump Market by Product (Accessories (Dedicated (Volumetric Pumps, Insulin Pumps, Enteral Pumps) & Non-dedicated), Devices (Traditional, Specialty)), Application (Oncology, Diabetes, Pain Management), End User - Global Forecast to 2030
The global ASEAN infusion pump market, valued at US$1.18 billion in 2024, stood at US$1.26 billion in 2025 and is projected to advance at a resilient CAGR of 7.1% from 2025 to 2030, culminating in a forecasted valuation of US$1.78 billion by the end of the period. The ASEAN infusion pump market is experiencing significant growth, driven by heightened healthcare awareness and enhanced access to sophisticated medical technologies throughout the region.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Syringes Market Size by Type (General & Specialized Syringes (insulin, tuberculin)), Usability (Sterilizable/reusable (hypodermic, oral) & Disposable Syringes (conventional, safety, prefilled)), Material (Glass & Plastic Syringes)- Global Forecast to 2021
The global syringes market size is projected to grow at a CAGR of 8.7%. High prevalence of chronic diseases across the globe, rising geriatric population, increasing adoption of safety syringes, technological advancements, and increasing demand for vaccines are supporting the market growth of syringes. However, high cost of safety syringes and increasing incidence of needle stick injuries are the major challenges in global Market.
- Published: November 2016
- Price: $ 4950
- TOC Available:
-
Europe Infusion Pump Market by Product [Accessories (Dedicated, Non-dedicated), Device (Insulin, Syringe, Volumetric, Enteral, PCA Pump)], Application (Chemotherapy, Diabetes, Analgesia), Mode of Administration (Subcutaneous, Epidural) - Forecast to 2031
The Europe infusion pump market, valued at USD 4.78 billion in 2025, stood at USD 5.10 billion in 2026 and is projected to advance at a resilient CAGR of 6.8% from 2026 to 2031, culminating in a forecasted valuation of USD 7.09 billion by the end of the period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Portable Medical Devices Market; By Equipment (Cardiac, Respiratory, Hemodynamic, Fitness & Wellness, Independent Ageing, Insulin pumps, Ultrasound), Semiconductor Components (Memory, PMIC, Processor, Display, Sensor, Connectivity) (2013 – 2018)
There has been an increasing focus on bringing in wireless communication capabilities into the healthcare industry with the evident advantages associated with wireless technologies. This trend has resulted in more and more portable medical devices being integrated with various wireless technologies like Wi-Fi, Bluetooth, ANT+ and ZigBee. These devices that are portable and have wireless capabilities are referred to as mobile medical devices. Measuring and monitoring applications in healthcare has become much more convenient with display or representation of the data on a mobile computing device, typically a smart-phone or a tablet.
- Published: June 2013
- Price: $ 4950
- TOC Available:
-
Biosimilars Market by Drug Class (mAbs (Adalimumab, Infliximab, Rituximab, Trastuzumab), GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1), Indication (Oncology, Autoimmune, Diabetes, Obesity), Competitive Landscape, Region - Global Forecast to 2035
The global biosimilars market, valued at US$32.75 billion in 2024, stood at US$35.04 billion in 2025 and is projected to advance at a resilient CAGR of 7.5% from 2025 to 2035, culminating in a forecasted valuation of US$72.29 billion by the end of the period. This growth is driven by several key factors, including a rising number of regulatory approvals and product launches, the patent expiries of major biologics, and the increasing prevalence of chronic diseases that require effective and affordable treatment options.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Protein Engineering Market by Technology (Rational Design, Irrational Design), Product & Service (Instrument, Consumables), Protein Type (Monoclonal Antibodies, Insulin), End User (Academics Institutes, Biopharmaceuticals, CROs) & Region - Global Forecast to 2024
The global protein engineering market growth is primed to transition from $2.2 billion in 2019 to $3.9 billion by 2024, showcasing a strong CAGR of 12.4%. The growth of this market is majorly driven by factors such as the increasing investments in synthetic biology and the growing focus on protein-based drug development by pharmaceutical and biotechnology companies.
- Published: January 2020
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
